Taipei Medical University, Wan Fang Hospital
Taipei, 116, Taiwan
NCT Number: NCT00958802
Platelet-rich plasma (PRP) has mixed growth factors such as TGF-ß1 and TGF-ß2, vascular epithelial growth factor (VEGF), platelet-derived growth factor (PDGF), and insulin-like growth factor (IGF). These growth factors appear to play an important role in wound healing and are assumed as promoters of tissue regeneration. Moreover, PRP was used as injectable scaffold seeded with chondrocytes to regenerate cartilage. In their previous study, the investigators concluded that growth factors in PRP can effectively react as a growth factor cocktail to induce human nucleus pulposus proliferation and differentiation, and also promote tissue-engineered nucleus pulposus formation. The investigators also have a hypothesis that PRP can promote tissue-engineered microtia auricular cartilage formation. TGF- ß1 exists in the highest concentration and is more important among all of the growth factors released from PRP. So TGF- ß1 can be used as the core ingredient and the indicator for applying PRP in these studies. The aim of this study was to compare the histological and biochemical character of microtia chondrocytes treated with and without PRP.
Looking for future studies?
Notify MeAll sexes
Interventional
Early Phase 1
Taipei, 116, Taiwan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PRP was extracted from total blood and TGF-b1 was used as indicator
Microtia chondrocyte culture with FBS medium only
Time frame: 4 weeks
Taipei Medical University WanFang Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05963659
Alcohol Dependence, Alcohol-Related Disorders
Hefei, Anhui, China
View Trial DetailsNCT03771066
Congenital Abnormalities, Congenital Microtia
San Luis Obispo, California, United States
View Trial DetailsNCT04351893
Bone Diseases, Bone Diseases, Developmental
Los Angeles, California, United States
View Trial DetailsNCT02224677
Bone Diseases, Bone Diseases, Developmental
Los Angeles, California, United States
View Trial Details